• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION EVOLUT PRO TRANSCATHETER AORTIC VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION EVOLUT PRO TRANSCATHETER AORTIC VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number EVOLUTPRO-29-US
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cardiac Arrest (1762); Death (1802); High Blood Pressure/ Hypertension (1908); Low Blood Pressure/ Hypotension (1914); Blood Loss (2597)
Event Date 12/05/2018
Event Type  Death  
Manufacturer Narrative
(b)(4).Product analysis: the product was discarded by the customer; therefore, no product analysis can be performed.Conclusion: without return of the product, no definitive conclusions could be drawn regarding the clinical observation.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information that during the implant of this transcatheter bioprosthetic valve, at 80% deployment, hypotension was noted.Medication was administered.Hypertension was noted and electrocardiogram (ecg) indicated asystole.The system was removed and cardiopulmonary resuscitation (cpr) was initiated.Pulmonary bleeding was suspected as bleeding from the mouth was noted.Thirty minutes of cpr was performed, and blood pressure and heart rate recovered.A valve was not implanted.No additional adverse patient effects were reported.
 
Manufacturer Narrative
Additional information was received: it was suspected that the pulmonary bleeding occurred due to hypertension.Per the physician, there was no evidence to suggest that the valve caused or contributed to the pulmonary bleeding.One day after the procedure, the patient expired.The cause of death was pulmonary hemorrhage.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVOLUT PRO TRANSCATHETER AORTIC VALVE
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key8203633
MDR Text Key131636409
Report Number2025587-2018-03577
Device Sequence Number1
Product Code NPT
UDI-Device Identifier00763000017835
UDI-Public00763000017835
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P130021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/09/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/28/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/03/2020
Device Model NumberEVOLUTPRO-29-US
Device Catalogue NumberEVOLUTPRO-29-US
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/03/2019
Date Device Manufactured07/23/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death; Required Intervention;
Patient Age89 YR
Patient Weight70
-
-